Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Galena Biopharma shares jump 26% after news that drug will enter late-stage trial
Galena Biopharma shares jump 26% after news that drug will enter late-stage trial
Galena Biopharma shares jump 26% after news that drug will enter late-stage trial
Submitted by
admin
on December 28, 2016 - 11:20am
Source:
Marketwatch
News Tags:
Galena Biopharma
GALE-401
clinical trials
thrombocythemia
Headline:
Galena Biopharma shares jump 26% after news that drug will enter late-stage trial
Do Not Allow Advertisers to Use My Personal information
